A carregar...
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
BACKGROUND: The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55–69. Knowing how the potential benefits and harms of screening vary by an individual’s risk of developing prostate cancer could infor...
Na minha lista:
| Publicado no: | PLoS Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924639/ https://ncbi.nlm.nih.gov/pubmed/31860675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002998 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|